The Foundation for NIH, as part of its portfolio, manages several large biomedical research partnerships or Key Initiatives. These partnerships leverage the resources of the National Institutes of Health with the public and private sectors, including government agencies, industry, academia, foundations, associations, and the philanthropic community.
A unique public-private collaboration has launched the Lung Cancer Master Protocol (Lung-MAP) trial, a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles.
The Accelerating Medicines Partnership (AMP) is a bold new venture between the National Institutes of Health, 10 biopharmaceutical companies and several non-profit organizations to transform the current model for developing new diagnostics and treatments by jointly identifying and validating promising biological targets of disease. Through the FNIH, AMP partners will invest more than $230 million over five years in the first projects, which focus on Alzheimer’s disease, type 2 diabetes, and the autoimmune disorders rheumatoid arthritis and systemic lupus erythematosus (lupus).
This groundbreaking initiative expands the science of personalized medicine. The study of biomarkers creates the potential to individualize medical treatment by determining how a drug works in the body and identifying patients likely to respond to targeted medicines and therapies.
Funded by the Gates Foundation, Grand Challenges in Global Health encompasses 43 project across 33 countries, working toward scientific breakthroughs to prevent, treat, and cure diseases that kill millions each year.
Poor nutrition is linked to more than half of all child deaths worldwide. This initiative, funded by the Gates Foundation, draws together an international group of science investigators to study the inter-relationship between enteric infections and malnutrition to reduce its devastating effects.
The Foundation for NIH is one of 19 consortia comprising the Collaboration for AIDS Vaccine Discovery. Funded by the Gates Foundation, this initiative is aimed toward developing an effective AIDS vaccine.
The Sports and Health Research Program (SHRP) is an innovative partnership among the National Institutes of Health (NIH), the National Football League (NFL) and the FNIH. Launched in 2012, the program aims to help accelerate the pursuit of research to enhance the health of athletes at all levels, past, present and future, and to extend the impact of that research beyond the playing field to benefit others in the general population, including members of the military.
Photo courtesy of Mitch Loeber under the Creative Commons license
What We Do
What is the National Institutes of Health?
The National Institutes of Health (NIH) is a part of the U.S. Department of Health and Human Services. Comprised of 27 institutes and centers, the NIH is the primary federal agency for conducting and supporting medical research.
NIH scientists investigate ways of treating, preventing, and even curing common and rare diseases. Learn more by visiting NIH's Web site.
Latest Press Releases